# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001558370-25-006992
Filing Date
2025-05-08
Accepted
2025-05-08 16:30:11
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-05-08

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | plx-20241231xars.pdf | ARS | 1258598
| Complete submission text file | 0001558370-25-006992.txt |  | 1733070

Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-33357 | Film No.: 25926755
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)